Expert Ratings for Gilead Sciences
Portfolio Pulse from Benzinga Insights
Gilead Sciences (NASDAQ:GILD) has received 2 somewhat bullish and 7 indifferent analyst ratings in the last quarter. The average price target given by these analysts is $88.22, which is higher than the current price of $80.64. The average price target has increased by 2.88% over the past month.
July 24, 2023 | 12:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Gilead Sciences has received mostly indifferent analyst ratings, with a few somewhat bullish. The average price target is above the current price, indicating potential upside.
Analyst ratings can significantly influence stock prices. In this case, Gilead Sciences has received mostly indifferent ratings, but the average price target given by the analysts is higher than the current price. This suggests that the analysts see potential upside for the stock, which could positively impact its price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100